Linezolid in the treatment of patients with MDR TB and XDR TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Experience of Bedaquiline use in treatment of XDR-TB patients Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India Source: Eur Respir J , 49 (3) 1601699; DOI: 10.1183/13993003.01699-2016 Year: 2017
Active pharmacovigilance for multidrug-resistant tuberculosis patients treated with Linezolid, Belarus – 2014-2015 Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017
Treatment of MDR-TB Source: International Congress 2015 – CC1 Diagnosis and management of MDR-TB Year: 2015
Use of linezolid in complex MDR-TB cases Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Clinical experience of clofazimine in the treatment of MDR-TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Administration of linezolid, bedaquiline and imipenem in treatment of patients with extensively drug-resistant tuberculosis Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Effectiveness and safety of six month chemotherapy course of XDR TB including bedaquiline and linezolid Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Prevalence of pre-XDR-TB, XDR-TB among MDR-TB Patients registered at Ojha Institute of Chest Diseases, Karachi Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Management of contact of patients with MDR-TB Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence Year: 2017
A retrospective analysis of quinolone prescriptions for tuberculosis in two North Birmingham hospitals Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Prospective study analysing prevalence of XDR TB in Mumbai, India Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016